Head and Neck Cancer Trial, Recruiting NCT01473784 Sponsor: Ohio State University Comprehensive Cancer Center Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT01473784
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who need diagnostic or treatment procedures for non-cancerous or cancerous conditions of the mouth or throat area, including tumours of the tongue, tongue base, tonsils, palate, parts of the throat, or the voice box (larynx)
  • People whose mouth and throat can be opened wide enough to allow the robotic surgical instruments to be used
  • People who are able to provide written consent, or for whom the overseeing ethics board has approved a consent waiver

Who may not be able to join:

  • People who have an unexplained fever or an active, untreated infection
  • People who are pregnant
  • People who have had previous head or neck surgery that would prevent a robotic or through-the-mouth procedure from being performed — this is decided by the treating doctor on a case-by-case basis (note: this restriction does not apply to participants in the non-surgical part of the trial)
  • People who have medical conditions that make general anaesthesia or through-the-mouth surgical approaches unsafe
  • People who are unable to give informed consent
  • People for whom, during the procedure itself, the surgeon cannot get a clear enough view of the anatomy to safely carry out the surgical approach through the mouth (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Enver Ozer, MD, Ohio State University

Phone: 1-800-293-5066

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University Comprehensive Cancer Center
Registry
ClinicalTrials.gov
Start date
3 December 2007
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Determine the feasibility of the TORS in patients with oral and laryngopharyngeal benign and malignant lesions.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov